Consequently, expression of those FoxO.A3 mutants is able to antagonize many PI3K/PKB-dependent functions, including their antiapoptotic and proliferative effects in tumor cells (10, 11) suggesting FoxOs to act as tumor suppressors downstream of PI3K/PKB signaling. This evidence concerns the gene AKT1 and neoplasm.